Analysis of simultaneous modulated accelerated radiotherapy (SMART) for nasopharyngeal carcinomas

Journal of Radiation Research

Volumn 55, Issue 4, 2014, Pages 794-802

  Tang, Jian Min ^a   Ma, Xiu Mei ^a   Hou, Yan Li ^a   Dai, Li Yan ^a   Cao, Hong Bin ^a   Ye, Ming ^a   Bai, Yong Rui ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

intensity modulated radiotherapy; nasopharygeal carcinoma; prognosis; simultaneous modulated accelerated radiotherapy; toxicity

Indexed keywords

CHEMORADIOTHERAPY; CHEMOTHERAPY; CONCURRENCY CONTROL; DIAGNOSIS; PATHOLOGY; RADIOTHERAPY;

ACCELERATED RADIOTHERAPY; CLINICAL OUTCOME; CONCURRENT CHEMORADIOTHERAPY; DISTANT METASTASIS; GROSS TUMOR VOLUME; INTENSITY-MODULATED RADIOTHERAPY; NASOPHARYGEAL CARCINOMA; NASOPHARYNGEAL CARCINOMA; PROGNOSE; SIMULTANEOUS MODULATED ACCELERATED RADIOTHERAPY;

TOXICITY;

ADOLESCENT; ADULT; ADVERSE EFFECTS; AGED; CHEMORADIOTHERAPY; CHILD; COMPUTER ASSISTED RADIOTHERAPY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PROCEDURES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHEMORADIOTHERAPY; CHILD; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; YOUNG ADULT;

EID: 84905226702     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1093/jrr/rru012     Document Type: Article

References (42)

1. Hoppe RT, Goffinet DR, Bagshaw MA. Carcinoma of the nasopharynx. Eighteen years' experience with megavoltage radiation therapy. Cancer 1976;37:2605-12.
2. Mesic JB, Fletcher GH, Goepfert H. Megavoltage irradiation of epithelial tumors of the nasopharynx. Int J Radiat Oncol Biol Phys 1981;7:447-53.
3. Chu AM, Flynn MB, Achino E et al. Irradiation of nasopha-ryngeal carcinoma: correlations with treatment factors and stage. Int J Radiat Oncol Biol Phys 1984;10:2241-9.
4. Bailet JW, Mark RJ, Abemayor E et al. Nasopharyngeal carcinoma: treatment results with primary radiation therapy. Laryngoscope 1992;102:965-72.
5. Lee AW, Lau WH, Tung SY et al. Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group. J Clin Oncol 2005;23:6966-75.
6. Lee AW, Sze WM, Au JS et al. Treatment results for nasopha-ryngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys 2005;61:1107-16.
7. Wolden SL, Chen WC, Pfister DG et al. Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys 2006;64:57-62.
8. Ng WT, Lee MC, Hung WM et al. Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for naso-pharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2010;79: 420-8.
9. Xiao WW, Huang SM, Han F et al. Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy: long-term results of a phase 2 study. Cancer 2011;117: 1874-83
10. International Commission on Radiation Units and Measurements. Prescribing, recording, and reporting photon beam therapy. Report 50. Bethesda, MD: ICRU, 1993.
11. International Commission on Radiation Units and Measurements. Prescribing, recording and reporting photon beam therapy (supplement to ICRU report 50). Report 62. Bethesda, MD: ICRU, 1999.
12. Al-Sarraf M, LeBlanc M, Giri PG et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol 1998;16:1310-7.
13. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer. Int J Radiat Oncol Biol Phys 1995;31:1341-6.
14. Kam MK, Chau RM, Suen J et al. Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation. Int J Radiat Oncol Biol Phys 2003;56:145-57.
15. Hunt MA, Zelefsky MJ, Wolden S et al. Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer. Int J Radiat Oncol Biol Phys 2001;49:623-32.
16. Cheng JC, Chao KS, Low D. Comparison of intensity modulated radiation therapy (IMRT) treatment techniques for nasopharyngeal carcinoma. Int J Cancer 2001;96:126-31.
17. Xia P, Fu KK, Wong GW et al. Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2000;48:329-37.
18. Luo RX, Tang QX, Guo KP et al. Comparison of continuous and split-course radiotherapy for nasopharyngeal carcinoma-an analysis of 1446 cases with squamous cell carcinoma Grade 3. Int J Radiat Oncol Biol Phys 1994;30:1107-9.
19. Kwong DL, Sham JS, Chau DT et al. The effect of interruptions and prolonged treatment time in radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1997;39:703-10.
20. Lee AW, Chan DK, Fowler JF et al. Effect of time, dose and fractionation on local control of nasopharyngeal carcinoma. Radiother Oncol 1995;36:24-31.
21. Marks JE, Bedwinek JM, Lee F et al. Dose-response analysis for nasopharyngeal carcinoma: an historical perspective. Cancer 1982;50:1042-50.
22. Teo PM, Leung SF, Lee WY et al. Intracavitary brachytherapy significantly enhances local control of early T-stage nasopharyngeal carcinoma: the existence of a dose-tumor control relationship above conventional tumoricidal dose. Int J Radiat Oncol Biol Phys 2000;46:445-58.
23. Le QT, Tate D, Koong A et al. Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2003;56:1046-54.
24. Hara W, Loo BW, Goffinet DR et al. Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2008;71:393-400.
25. Marks JE, Bedwinek JM, Lee F et al. Dose-response analysis for nasopharyngeal carcinoma: an historical perspective. Cancer 1982;50:1042-50.
26. Lee N, Xia P, Quivey JM et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys 2002;53:12-22.
27. Kam MK, Teo PML, Chau RMC et al. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys 2004;60:1440-50.
28. Wu S, Xie C, Jin X et al. Simultaneous modulated accelerated radiation therapy in the treatment of nasopharyngeal carcinoma: a local center's experience. Int J Radiat Oncol Biol Phys 2006;66:44-6.
29. Kwong DL, Sham JS, Leung LH et al. Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2006;64:374-81.
30. Koom WS, Kim TH, Shin KH et al. SMART (simultaneous modulated accelerated radiotherapy) for locally advanced nasopharyngeal carcinomas. Head Neck 2008;30:159-69.
31. Lin S, Pan J, Han L et al. Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series. Int J Radiat Oncol Biol Phys 2009;75:1071-8.
32. Lee N, Harris J, Garden AS et al. Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: Radiation Therapy Oncology Group phase II trial 0225. J Clin Oncol 2009;27:3684-90.
33. Bakst RL, Lee N, Pfister DG et al. Hypofractionated dose-painting intensity modulated radiation therapy with chemotherapy for nasopharyngeal carcinoma: a prospective trial. Int J Radiat Oncol Biol Phys 2011;80:148-53.
34. Wee J, Tan EH, Tai BC et al. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety. J Clin Oncol 2005;23:6730-8.
35. Chan AT, Teo PM, Ngan RK et al. Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial. J Clin Oncol 2002;20:2038-44.
36. Lee AW, Tung SY, Chan AT et al. Preliminary results of a randomized study (NPC-9902 Trial) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2006;66:142-51.
37. Chen Y, Liu MZ, Liang SB et al. Preliminary results of a prospective randomized trial comparing concurrent chemora-diotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of China. Int J Radiat Oncol Biol Phys 2008;71:1356-64.
38. Chitapanarux I, Lorvidhaya V, Kamnerdsupaphon P et al. Chemoradiation comparing cisplatin versus carboplatin in locally advanced nasopharyngeal cancer: randomized, nonin-feriority, open trial. Eur J Cancer 2007;43:1399-406.
39. Kwong DL, Sham JS, Au GK et al. Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study. J Clin Oncol 2004;22:2643-53.
40. Langendijk JA, Leemans CR, Buter J et al. The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature. J Clin Oncol 2004;22:4604-12.
41. Kim K, Wu HG, Kim HJ et al. Intensity-modulated radiation therapy with simultaneous integrated boost technique following neoadjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma. Head Neck 2009;31:1121-8.
42. Palazzi M, Guzzo M, Tomatis S et al. Improved outcome of nasopharyngeal carcinoma treated with conventional radiotherapy. Int J Radiat Oncol Biol Phys 2004;60:1451-8.